Kraig Biocraft Laboratories, Inc. (KBLB)
USD 0.09
(1.12%)
USD 0.09
(1.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.24 Million | -1.88 Million | -1.8 Million | -1.25 Million | -1.08 Million | -235 Thousand |
| Net Income | -3.02 Million | -3.84 Million | -8.04 Million | -4.97 Million | -2.9 Million | -1.16 Million |
| Depreciation & Amortization | 27.62 Thousand | 28.1 Thousand | 26.13 Thousand | 28.07 Thousand | 30.78 Thousand | 26.63 Thousand |
| Deferred income taxes | -279.24 Thousand | -234.70 | -842.38 | -2845.46 | -677.02 | - |
| Stock-based compensation | 225 Thousand | 234.69 Thousand | 242.1 Thousand | 2.84 Million | 677.02 Thousand | 72.57 Thousand |
| Change in working capital | 873.3 Thousand | 499.63 Thousand | 618.48 Thousand | 733.71 Thousand | 1.09 Million | 842.78 Thousand |
| Other non-cash items | 938.61 Thousand | 1.42 Million | 5.6 Million | 2.95 Million | 699.35 Thousand | 64.56 Thousand |
| Investing Cash Flow | -6399.00 | -5021.00 | -547.37 Thousand | - | -100.79 Thousand | -11.44 Thousand |
| Investments in PPE | -6399.00 | -5021.00 | -97.15 Thousand | - | -100.79 Thousand | -11.44 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.58 Million | - | -450.21 Thousand | - | - | - |
| Sales/Maturities of investments | 2.58 Million | - | - | - | - | - |
| Other Investing Activities | - | - | -450.22 | - | - | - |
| Financing Cash Flow | -60 Thousand | 3.39 Million | 3.88 Million | 1.94 Million | 1.3 Million | 242 Thousand |
| Debt repayment | -60 Thousand | -100 Thousand | -50 Thousand | -40 Thousand | -20 Thousand | -242 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 739.86 Thousand | 266.33 Thousand | 17.49 Thousand | 1 Million | 1.07 Billion |
| Other Financing Activities | - | 2.76 Million | 3.67 Million | 1.96 Million | 320 Thousand | -1.07 Billion |
| Accounts receivables | - | - | - | - | - | 25.87 Thousand |
| Accounts payables | 1298.00 | 138.15 Thousand | 199.72 Thousand | 39.05 Thousand | 314.36 Thousand | 136.32 Thousand |
| Inventory | -304.00 | -6580.00 | - | - | - | 5.19 Million |
| Other working capital | 872.31 Thousand | 368.05 Thousand | 418.76 Thousand | 694.65 Thousand | 777.46 Thousand | -4.51 Million |
| Cash at beginning of period | 3.86 Million | 2.35 Million | 816.9 Thousand | 125.02 Thousand | 13.69 Thousand | 18.15 Thousand |
| Cash at end of period | 2.55 Million | 3.86 Million | 2.35 Million | 816.9 Thousand | 125.02 Thousand | 13.69 Thousand |
| Capital Expenditure | -6399.00 | -5021.00 | -97.15 Thousand | - | -100.79 Thousand | -11.44 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.31 Million | 1.5 Million | 1.53 Million | 691.88 Thousand | 111.32 Thousand | -4453.00 |
| Free Cash Flow | -1.25 Million | -1.89 Million | -1.89 Million | -1.25 Million | -1.18 Million | -246.45 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.6 Million | -507.87 Thousand | -3.02 Million | -1.32 Million | -549.27 Thousand | -589.09 Thousand |
| Depreciation & Amortization | 6730.00 | 6729.00 | 27.62 Thousand | 7578.00 | 7285.00 | 6140.00 |
| Deferred income taxes | - | - | -279.24 Thousand | -595.63 | -54.03 | -82.48 |
| Stock-based compensation | 856.38 | -67.15 Thousand | 225 Thousand | 595.63 Thousand | 54.03 Thousand | 82.48 Thousand |
| Change in working capital | 202.68 Thousand | 102.18 Thousand | 873.3 Thousand | 328.91 Thousand | 214.82 Thousand | 182.92 Thousand |
| Other non-cash items | 892.74 Thousand | -44.92 Thousand | 938.61 Thousand | 660.42 Thousand | 78.44 Thousand | 127.43 Thousand |
| Investing Cash Flow | - | - | -6399.00 | - | 1.72 Million | -1.72 Million |
| Investments in PPE | 510.77 Thousand | - | -6399.00 | - | -6.40 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -2.58 Million | - | - | -2.58 Million |
| Sales/Maturities of investments | - | - | 2.58 Million | - | 1.72 Million | 860 Thousand |
| Other Investing Activities | - | - | - | - | -6392.60 | -1727.81 |
| Financing Cash Flow | -15 Thousand | -15 Thousand | -60 Thousand | -15 Thousand | -15 Thousand | -15 Thousand |
| Debt repayment | -15 Thousand | -15 Thousand | -60 Thousand | -15 Thousand | -15 Thousand | -15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -15 Thousand | - | - | - | -15.00 |
| Accounts receivables | - | - | - | 0.30 | - | - |
| Accounts payables | 6710.00 | -32.18 Thousand | 1298.00 | 21.98 Thousand | -8266.00 | -28.34 Thousand |
| Inventory | - | - | -304.00 | -0.30 | - | - |
| Other working capital | 195.97 Thousand | 134.36 Thousand | 872.31 Thousand | 306.92 Thousand | 223.09 Thousand | 211.27 Thousand |
| Cash at beginning of period | 2.04 Million | 2.55 Million | 3.86 Million | 2.89 Million | 1.43 Million | 3.45 Million |
| Cash at end of period | 1.52 Million | 2.04 Million | 2.55 Million | 2.55 Million | 2.89 Million | 1.43 Million |
| Capital Expenditure | 510.77 Thousand | - | -6399.00 | - | -6.40 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -525.77 Thousand | -504.52 Thousand | -1.31 Million | -342.72 Thousand | 1.45 Million | -2.01 Million |
| Free Cash Flow | - | -489.52 Thousand | -1.25 Million | -327.72 Thousand | -248.72 Thousand | -272.59 Thousand |
RAIN
SUNTF
SAFARI
ZENITHEXPO
SISE
MADHUVEER